Our research teams investigate the safety, inner workings, and advances in health monitoring—so that new technologies have a positive impact as they become increasingly capable.
Understanding how AI models and biosensing systems work internally, as a foundation for safety and trustworthy outcomes.
Ensuring that AI systems remain helpful, honest, and aligned with human values as they become more capable.
Developing and validating continuous biosensing technologies for real-time health tracking and disease management.
Conducting rigorous, peer-reviewed research into mast cell activation and neuroinflammation with clinical partners.
A continuous-biosensing study of how heat exposure drives mast cell activation in MCAS, revealing distinct physiological signatures that precede reported symptoms.
Interpretable machine-learning models forecast MCAS flares from continuous biosignals while making their reasoning transparent to patients and clinicians.
A validation study comparing continuous MCT-1 biosignals against established clinical reference measures across activity, sleep, and flare conditions.
| Date | Category | Title |
|---|---|---|
| Jul 15, 2026 | Machine Learning | From signal to insight: the MCT - 1 analytics pipeline |
| Jul 8, 2026 | Methods | Personalizing baselines: individual variability in activation |
| Jun 27, 2026 | Clinical Research | Correlating inflammatory markers with patient-reported symptoms |
| Jun 20, 2026 | Privacy & Ethics | Privacy-preserving models for continuous health monitoring |
| Jun 13, 2026 | Biomarkers | Skin temperature dynamics during flares |
| Jun 6, 2026 | Health Monitoring | Heart rate variability as a marker of mast cell activation |
| May 30, 2026 | Machine Learning | Machine learning for trigger identification in mast cell disorders |
| May 23, 2026 | Biomarkers | Signatures of histamine release in continuous physiological data |
| May 16, 2026 | Methods | Continuous vs. episodic measurement in MCAS |
| May 9, 2026 | Health Monitoring | Detecting mast cell activation from wearable biosignals |
| May 8, 2026 | Health Monitoring | Real-time biomarker detection in mast cell activation syndrome |
| May 7, 2026 | Interpretability | Understanding neural patterns in health prediction |
| May 2, 2026 | Interpretability | Machine learning model interpretability in biosensing data analysis |
| Apr 30, 2026 | Clinical | Neuroinflammation markers in related conditions |
| Apr 25, 2026 | Health Monitoring | Patient empowerment through real-time health data access |
| Apr 22, 2026 | Safety | Privacy-first architecture for wearable health data |
| Apr 18, 2026 | Clinical | Multi-omics integration for personalized medicine |
| Apr 15, 2026 | Alignment | Ethical frameworks for AI-assisted medical diagnosis |
| Apr 10, 2026 | Policy | Regulatory considerations for AI medical devices |
| Apr 8, 2026 | Health Monitoring | Continuous biosensing validation in patient cohorts |
| Apr 3, 2026 | Health Monitoring | Longitudinal biomarker tracking in chronic conditions |
| Mar 27, 2026 | Safety | Federated learning for distributed health data analysis |
| Mar 20, 2026 | Health Monitoring | Wearable sensor calibration and validation methods |
| Mar 13, 2026 | Interpretability | Deep learning for time series anomaly detection |
| Mar 6, 2026 | Clinical | Cross-platform data integration and harmonization |
| Feb 27, 2026 | Health Monitoring | Behavioral interventions driven by biosensing insights |
| Feb 20, 2026 | Policy | Real-world evidence generation from continuous monitoring |
| Feb 13, 2026 | Clinical | Patient stratification for precision treatment selection |